Peptide IDR-1018: Modulating the immune system and targeting bacterial biofilms to treat antibiotic-resistant bacterial infections

Journal of Peptide Science

Volumn 21, Issue 5, 2015, Pages 323-329

  Mansour, Sarah C ^a   De La Fuente Núñez, César ^a   Hancock, Robert E W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

anti biofilm; anti infective; immunomodulatory; peptide

Indexed keywords

IDR 1018; IMMUNOMODULATING AGENT; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; INNATE DEFENSE REGULATING PEPTIDE 1018;

AMINO ACID SEQUENCE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIINFLAMMATORY ACTIVITY; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BIOFILM; BRAIN DAMAGE; BRAIN MALARIA; CELL DIFFERENTIATION; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG TARGETING; HERPESVIRIDAE; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS AUREUS; WOUND HEALING; ANIMAL; BACTERIAL INFECTIONS; BOVINE; DRUG EFFECTS; DRUG POTENTIATION; HUMAN; MULTIDRUG RESISTANCE;

BACTERIA (MICROORGANISMS); BOVINAE; HERPESVIRIDAE; MURINAE; MYCOBACTERIUM TUBERCULOSIS; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL INFECTIONS; BIOFILMS; CATTLE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; HUMANS; WOUND HEALING;

EID: 84928802858     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.2708     Document Type: Review

References (35)

1. Zasloff M,. Antimicrobial peptides of multicellular organisms. Nature 2002; 415 (6870): 389-395.
2. Fjell CD, Hiss JA, Hancock REW, Schneider G,. Designing antimicrobial peptides: form follows function. Nat. Rev. Drug Discov. 2011; 11 (1): 37-51.
3. Hancock REW, Lehrer R, Cationic peptides: a new source of antibiotics. Trends Biotechnol. 1998; 16 (2): 82-88.
4. de la Fuente-Núñez C, Korolik V, Bains M, Nguyen U, Breidenstein EB, Horsman S, Lewenza S, Burrows L, Hancock REW,. Inhibition of bacterial biofilm formation and swarming motility by a small synthetic cationic peptide. Antimicrob. Agents Chemother. 2012; 56 (5): 2696-2704.
5. de la Fuente-Núñez C, Reffuveille F, Haney EF, Straus SK, Hancock REW,. Broad-spectrum anti-biofilm peptide that targets a cellular stress response. PLoS Pathog. 2014; 10 (5): e1004152.
6. Overhage J, Campisano A, Bains M, Torfs EC, Rehm BH, Hancock REW,. Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect. Immun. 2008; 76 (9): 4176-4182.
7. Mansour SC, Pena O, Hancock REW,. Host defense peptides: front-line immunomodulators. Trends Immunol. 2014; 35 (9): 443-450.
8. Bowdish DM, Davidson DJ, Lau YE, Lee K, Scott MG, Hancock REW,. Impact of LL-37 on anti-infective immunity. J. Leukoc. Biol. 2005; 77 (4): 451-459.
9. Tjabringa GS, Ninaber DK, Drijfhout JW, Rabe KF, Hiemstra PS,. Human cathelicidin LL-37 is a chemoattractant for eosinophils and neutrophils that acts via formyl-peptide receptors. Int. Arch. Allergy Immunol. 2006; 140 (2): 103-112.
10. Mookherjee N, Brown KL, Bowdish DM, Doria S, Falsafi R, Hokamp K, Roche FM, Mu R, Doho GH, Pistolic J, Powers JP, Bryan J, Brinkman FS, Hancock REW,. Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J. Immunol. 2006; 176 (4): 2455-2464.
11. Davidson DJ, Currie AJ, Reid GS, Bowdish DM, MacDonald KL, Ma RC, Hancock REW, Speert DP,. The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J. Immunol. 2004; 172 (2): 1146-1156.
12. Hall-Stoodley L, Costerton JW,. Stoodley bacterial biofilms: from the natural environment to infectious diseases. Nat. Rev. Microbiol. 2004; 2 (2): 95-108.
13. Costerton JW, Stewart PS, Greenberg EP,. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284 (5418): 1318-1322.
14. O'Toole G, Kaplan HB, Kolter R,. Biofilm formation as microbial development. Annu. Rev. Microbiol. 2000; 54: 49-79.
15. Kolter R,. Biofilms in lab and nature: a molecular geneticist's voyage to microbial ecology. Int. Microbiol. 2010; 13 (1): 1-7.
16. de la Fuente-Núñez C, Reffuveille F, Fernández L, Hancock REW,. Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies. Curr. Opin. Microbiol. 2013; 16 (5): 580-589.
17. Wieczorek M, Jenssen H, Kindrachuk J, Scott WR, Elliott M, Hilpert K, Cheng JT, Hancock REW, Straus SK,. Structural studies of a peptide with immune modulating and direct antimicrobial activity. Chem. Biol. 2010; 17 (9): 970-980.
18. Scott MG, Dullaghan E, Mookherjee N, Glavas N, Waldbrook M, Thompson A, Wang A, Lee K, Doria S, Hamill P, Yu JJ, Li Y, Donini O, Guarna MM, Finlay BB, North JR, Hancock REW,. An anti-infective peptide that selectively modulates the innate immune response. Nat. Biotechnol. 2007; 25 (4): 465-472.
19. Mookherjee N, Hamill P, Gardy J, Blimkie D, Falsafi R, Chikatamarla A, Arenillas DJ, Doria S, Kollmann TR, Hancock REW,. Systems biology evaluation of immune responses induced by human host defence peptide LL-37 in mononuclear cells. Mol. Biosyst. 2009; 5 (5): 483-496.
20. Nijnik A, Madera L, Ma S, Waldbrook M, Elliott MR, Easton DM, Mayer ML, Mullaly SC, Kindrachuk J, Jenssen H, Hancock REW,. Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment. J. Immunol. 2010; 184 (5): 2539-2550.
21. Thurlow LR, Hanke ML, Fritz T, Angle A, Aldrich A, Williams SH, Engebretsen IL, Bayles KW, Horswill AR, Kielian T,. Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo. J. Immunol. 2011; 186 (11): 6585-6596.
22. Pena OM, Afacan N, Pistolic J, Chen C, Madera L, Falsafi R, Fjell CD, Hancock REW,. Synthetic cationic peptide IDR-1018 modulates human macrophage differentiation. PLoS One 2013; 8 (1): e52449.
23. Murray PJ, Wynn TA,. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 2011; 11 (11): 723-737.
24. Cherkasov A, Hilpert K, Jenssen H, Fjell CD, Waldbrook M, Mullaly SC, Volkmer R, Hancock REW,. Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibiotic-resistant superbugs. ACS Chem. Biol. 2009; 4 (1): 65-74.
25. Steinstraesser L, Hirsch T, Schulte M, Kueckelhaus M, Jacobsen F, Mersch EA, Stricker I, Afacan N, Jenssen H, Hancock REW, Kindrachuk J,. Innate defense regulator peptide 1018 in wound healing and wound infection. PLoS One 2012; 7 (8): e39373.
26. Achtman AH, Pilat S, Law CW, Lynn DJ, Janot L, Mayer ML, Ma S, Kindrachuk J, Finlay BB, Brinkman FS, Smyth GK, Hancock REW, Schofield L,. Effective adjunctive therapy by an innate defense regulatory peptide in a preclinical model of severe malaria. Sci. Transl. Med. 2012; 4 (135): 135ra64.
27. Rivas-Santiago B, Castañeda-Delgado JE, Rivas Santiago CE, Waldbrook M, González-Curiel I, Leõn-Contreras JC, Enciso-Moreno JA, del Villar V, Mendez-Ramos J, Hancock REW, Hernandez-Pando R,. Ability of innate defence regulator peptides IDR-1002, IDR-HH2 and IDR-1018 to protect against Mycobacterium tuberculosis infections in animal models. PLoS One 2013; 8 (3): e59119.
28. Bolouri H, Sävman K, Wang W, Thomas A, Maurer N, Dullaghan E, Fjell CD, Ek CJ, Hagberg H, Hancock REW, Brown KL, Mallard C,. Innate defense regulator peptide 1018 protects against perinatal brain injury. Ann. Neurol. 2014; 75 (3): 395-410.
29. Hoffman LR, D'Argenio DA, MacCoss MJ, Zhang Z, Jones RA, Miller SI,. Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 2005; 436 (7054): 1171-1175.
30. Loutet SA, Valvano MA,. Extreme antimicrobial peptide and polymyxin B resistance in the genus burkholderia. Front. Microbiol. 2011; 2: 159.
31. Otto M, Bacterial evasion of antimicrobial peptides by biofilm formation. Curr. Top. Microbiol. Immunol. 2006; 306: 251-258.
32. Reffuveille F, de la Fuente-Núñez C, Mansour S, Hancock REW,. A broad-spectrum anti-biofilm peptide enhances antibiotic action against bacterial biofilms. Antimicrob. Agents Chemother. 2014.
33. Schierle CF, De la Garza M, Mustoe TA, Galiano RD,. Staphylococcal biofilms impair wound healing by delaying reepithelialization in a murine cutaneous wound model. Wound Repair Regen. 2009; 17 (3): 354-359.
34. Zhao G, Usui ML, Lippman SI, James GA, Stewart PS, Fleckman P, Olerud JE,. Biofilms and inflammation in chronic wounds. Adv. Wound Care (New Rochelle) 2013; 2 (7): 389-399.
35. Bosmann M, Ward PA,. The inflammatory response in sepsis. Trends Immunol. 2013; 34 (3): 129-136.